Form 8-K REPROS THERAPEUTICS INC. For: May 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Repros Therapeutics (RPRX) Tops Q1 EPS by 2c
May 10, 2016 9:21 AM EDTRepros Therapeutics (NASDAQ: RPRX) reported Q1 EPS of ($0.20), $0.02 better than the analyst estimate of ($0.22).
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
... More